Treatment of Helicobacter pylori

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 3

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jun 15, 2001; 7(3): 303-307
Published online Jun 15, 2001. doi: 10.3748/wjg.v7.i3.303

Table 3 Quadruple therapy

Therapy	Omeprazole
	Colloidal bismuth subcitrate
	Tetracycline
	Metronidazole
Dosing	o.d.
	120 mg q.d.s.
	500 mg q.d.s.
	400 mg q.d.s.
Duration	One week
Side effects	Common: nausea, diarrhoea, taste disturbances
H. pylori eradication	＞ 75% in MRS
H. pylori eradication	＞ 90% in MSS

o.d.: Once daily; q.d.s.: Four times daily; MRS: Metronidazole-resistant strains of H. pylori; MSS: Metronidazole-sensitive strains of H. pylori

Citation: Harris A. Treatment of Helicobacter pylori. World J Gastroenterol 2001; 7(3): 303-307
URL: https://www.wjgnet.com/1007-9327/full/v7/i3/303.htm
DOI: https://dx.doi.org/10.3748/wjg.v7.i3.303

Harris A. Treatment of Helicobacter pylori. World J Gastroenterol 2001; 7(3): 303-307 [PMID: 11819780 DOI: 10.3748/wjg.v7.i3.303]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.